Andrew Hollman Meyer serves as Executive at Janux Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Andrew Hollman Meyer has executed 11 insider transactions totaling $3.0M, demonstrating a bearish approach to their equity position. Their most recent transaction on Jan 2, 2026 involved selling 1,879 shares valued at $25.8K.
Andrew Hollman Meyer currently holds 83,095 shares of Janux Therapeutics, Inc. (JANX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Andrew Hollman Meyer has been a net seller of JANX stock. They have purchased $0 and sold $3.0M worth of shares.
Andrew Hollman Meyer's most recent insider trade was on Jan 2, 2026, when they sold 1,879 shares at $13.73 per share.
Get notified when new Form 4 filings are submitted
| $10.59 |
| Discretionary |
| Dec 1, 2025 | JANX | $88.7K | Sale | 2,700 | $32.85 | Discretionary |
| Dec 1, 2025 | JANX | $21.2K | Sale | 633 | $33.52 | Discretionary |
| Nov 14, 2025 | JANX | $35.3K | Option Exercise | 3,333 | $10.59 | Discretionary |
| Nov 14, 2025 | JANX | $100.0K | Sale | 3,333 | $30.00 | Discretionary |
| Oct 28, 2025 | JANX | $70.6K | Option Exercise | 6,666 | $10.59 | Discretionary |
| Oct 28, 2025 | JANX | $42.1K | Option Exercise | 9,999 | $4.21 | Discretionary |
| Oct 28, 2025 | JANX | $500.9K | Sale | 16,665 | $30.06 | Discretionary |
| Sep 27, 2024 | JANX | $210.5K | Option Exercise | 50,000 | $4.21 | Discretionary |
| Sep 27, 2024 | JANX | $2.3M | Sale | 50,000 | $45.96 | Discretionary |